Company: SMNR
Filing Date: 2025-08-13
Form Type: 424B3
Source: 0001193125-25-179226
Chunk: 78

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: 424B3
Chunk 78
---
-8565 Email: ksmith@advantageproxy.com You also may obtain additional information about Denali from documents filed with the SEC by following the instructions in the section titled “ Where You Can Find More Information.” If you are a holder of public shares and you intend to seek redemption of your public shares, you will need to deliver your public shares (either physically or electronically) to VStock, Denali’s transfer agent, at the address below prior to the Meeting. Holders must complete the procedures for electing to redeem their public shares in the manner described above prior to 5:00 p.m., Eastern Time, on August 29, 2025 (two business days before the Meeting) in order for their shares to be redeemed.If you have questions regarding the certification of your position or delivery of your stock, please contact: VStock Transfer, LLC 18 Lafayette Place Woodmere, New York 11598 Attention: Chief Executive Officer You may also obtain additional information about Denali from documents filed with the SEC by following the instructions in the section titled “ Where You Can Find More Information.” 33

SUMMARY OF THE PROXY STATEMENT

This summary highlights selected information from this proxy statement/prospectus but may not contain all of the information that may be important to you. You should read this entire proxy statement/prospectus, including the annexes and other documents referred to herein, carefully in their entirety. Please read these documents carefully as they are the legal documents that govern the Business Combination and your rights in the Business Combination.

Unless otherwise specified, all share calculations assume no exercise of the redemption rights by Denali’s shareholders.

The Parties to the Business Combination

Denali Capital Acquisition Corp.

Denali is a blank
check company incorporated on January 5, 2022 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more
businesses or entities.

On April 11, 2022, Denali consummated the IPO of 8,250,000 Public Units, including the issuance of 750,000 Public Units as a
result of the underwriters’ partial exercise of their over-allotment option. Each Public Unit consists of one Denali Class A Ordinary Share and one Public Warrant of Denali. The Public Units were sold at a price of $10.00 per unit,
generating gross proceeds to Denali of $82,500,000.

Den